Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 132Recruiting 72Active not recruiting 48Unknown 42Terminated 30Withdrawn 19Not yet recruiting 13Suspended 2Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Head and Neck Neoplasms 10Squamous Cell Carcinoma of Head and Neck 4Oropharyngeal Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Recurrent Head and Neck Carcinoma 1Postoperative Complications 1Pancreatic Neoplasms 1Nerve Compression Syndromes 1Nasopharyngeal Neoplasms 1Melanoma 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Eyelid Squamous Cell Carcinoma 1Endometrial Neoplasms 1Dihydropyrimidine Dehydrogenase Deficiency 1Colorectal Neoplasms 1Carotid Stenosis 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Accessory Nerve Injuries 1

Interventions

Magnetic Resonance Spectroscopy 2atezolizumab 1Radiotherapy 1Radiation 1Platinum 1Neck Dissection 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Oropharyngeal Neoplasms × Head & Neck × Clear all
NCT05050162 2026-05-07

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

NRG Oncology

Phase 2/3 Suspended
1,714 enrolled
Head & Neck

Carcinoma, Oropharyngeal Neoplasms

NCT06254911 2026-01-27

Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma

Emory University

Phase 2 Suspended
20 enrolled
Head & Neck

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡